{"nct_id":"NCT02761694","title":"Vevorisertib (ARQ 751) as a Single Agent or in Combination With Other Anti-Cancer Agents, in Solid Tumors With PIK3CA / AKT / PTEN Mutations (MK-4440-001)","status":"TERMINATED","status_verified_date":"2023-05","start_date":"2016-06-26","start_date_type":"ACTUAL","primary_completion_date":"2021-03-10","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["MRK"]}